← Back to catalogue
Published

ginsenoside

vr.tr.ginsenoside · thing-q59662497

Enable an agent to identify a ginsenoside, assess the composition and condition of material containing it, and determine which analytical, handling and use decisions the evidence supports.

Thing Registry Physical world and living systems PHY.MAT

Bundle → Layer → Finding → Questions Filled

6 bundles · 11 layers · 17 findings · 30 questions

Ginsenoside identity Resolve what the family label and individual congener names denote.

Family boundary

Establish the chemical and naming criteria for inclusion.

Membership criteria

Record the adopted definition and explicitly adjudicate related saponins and aglycones.

  1. Which structural and nomenclatural criteria qualify a compound as a ginsenoside under the adopted definition? definition
  2. How are non-dammarane named compounds, related saponins and free aglycones included, excluded or linked? boundary

Congener resolution

Connect names and identifiers to chemically explicit members.

Name-structure correspondence

Resolve aliases against complete structures while preserving ambiguity.

  1. Which structure, including stereochemistry, does each supplied congener name or synonym denote? definition
  2. Which authoritative records support its identifiers, and do those records describe the same stereochemical entity? provenance
Aglycone and sugars Describe the structural features needed to distinguish individual ginsenosides.

Aglycone configuration

Capture the core skeleton, substitutions and stereochemical assignment.

Core structure assignment

Identify structural differences that determine congener or stereoisomer identity.

  1. What aglycone skeleton, oxidation pattern and stereocentre assignments define this member? definition
  2. What evidence resolves the relevant epimers, including C-20 configuration where applicable? measurement

Sugar architecture

Capture attached carbohydrate residues and their arrangement.

Glycosidic structure assignment

Record sugar composition, connectivity and modifications without collapsing positional isomers.

  1. Which sugars are attached at which positions, with what sequence, linkage and anomeric configuration? definition
  2. Which analytical evidence distinguishes this arrangement from congeners with the same nominal mass or sugar count? measurement
Material assay and quality Establish what a supplied sample contains and how confidently it has been measured.

Identity testing

Evaluate the ability of analytical methods to identify the claimed members.

Analytical specificity

Connect identification confidence to standards, separation and structural evidence.

  1. Which reference standards and chromatographic, mass-spectrometric or NMR evidence support each assignment? measurement
  2. Which coeluting congeners or unresolved stereoisomers could invalidate that assignment? boundary

Composition and assay basis

Make congener quantities and purity claims comparable.

Quantitative profile

Separate actual analyte mass fractions from relative detector response and aggregate estimates.

  1. What is each measured congener's concentration, uncertainty and dry-mass or as-received reporting basis? measurement
  2. Does total ginsenoside content mean a sum of resolved analytes or an assay expressed against a surrogate standard? definition
  3. What residual solvents, water, related congeners or matrix components constrain acceptance for the intended use? action
Origin and transformation Track where a member came from and how its chemical identity may have changed.

Source history

Link material to its biological or preparative origin.

Origin attribution

Preserve botanical, isolation or synthesis evidence without treating origin as proof of structure.

  1. Was the material isolated from a documented species and plant part, synthesized, or obtained through conversion of another compound? provenance
  2. Which lot records and analytical results connect that origin to the material now being assessed? provenance

Conversion and stability

Record demonstrated changes under processing and storage conditions.

Congener change evidence

Distinguish observed transformations from presumed pathways.

  1. Under the recorded heat, pH, enzyme, microbial or storage conditions, which precursor and product congeners were actually measured? measurement
  2. What evidence distinguishes deglycosylation, epimerization or other chemical change from extraction loss or analytical variation? boundary
  3. Which storage conditions and retest interval are supported for this congener in this physical form or solvent? action
Properties and use evidence Connect member-specific physical properties and safety evidence to proposed actions.

Physical behaviour

Evaluate properties under conditions relevant to handling and experiments.

Preparation conditions

Record physical form, dissolution and thermal observations for an identified material.

  1. What solubility and solution stability were measured for the exact congener, solvent composition, temperature and pH? measurement
  2. Does a reported thermal value represent melting, desolvation or decomposition, and is any boiling-point claim experimentally supported? measurement

Permitted inferences and actions

Bound handling and use decisions by the specificity of available evidence.

Use-specific evidence

Match safety, biological and regulatory statements to the exact member, material and context.

  1. Which current safety documents, hazard classifications or exposure limits explicitly apply to this congener and supplied material? provenance
  2. Were cited biological results obtained with this purified congener, a metabolite or a mixed extract, and in what experimental system? boundary
  3. What evidence and jurisdiction-specific requirements must be satisfied before the proposed laboratory, food or medicinal use can proceed? action
Evidence and external alignment What the world already says about this thing, gathered so the model can be checked against it.

Reported evidence

Findings from the breadth pass, kept separate from the structural claims.

Check these first

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these check these first hold for the sense of ginsenoside this model covers, and on what evidence? provenance

Kinds and varieties

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these kinds and varieties hold for the sense of ginsenoside this model covers, and on what evidence? provenance

Identifiers and schemes

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these identifiers and schemes hold for the sense of ginsenoside this model covers, and on what evidence? provenance

Real-world use

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these real-world use hold for the sense of ginsenoside this model covers, and on what evidence? provenance

Typical measurements

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these typical measurements hold for the sense of ginsenoside this model covers, and on what evidence? provenance

Failure modes and hazards

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these failure modes and hazards hold for the sense of ginsenoside this model covers, and on what evidence? provenance

Neighbouring kinds and how to tell them apart

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these neighbouring kinds and how to tell them apart hold for the sense of ginsenoside this model covers, and on what evidence? provenance

Classifiers Filled

Family
Thing Registry
Category
Physical world and living systems
Entry kind
thing
Plane
PHY
Domain
PHY.MAT
Other names and narrower kinds
ginsenoside Rg1, ginsenoside Rg3, ginsenoside Rb1, ginsenoside Rf, ginsenoside B2, Chikusetsusaponin-V, ginsenoside Rd, (20R)-ginsenoside Rg3, Ginsenoside Rg5, ginsenoside F2, ginsenoside C-K, (20S)-ginsenoside Rh2

What it is Filled

A ginsenoside is a member of a family of triterpenoid saponin glycosides characteristic of Panax species, distinguished by their aglycone structures and attached sugar residues.

In scope

  • Family membership, congener names, synonyms and structure-specific identifiers
  • Aglycone skeleton, sugar residues, glycosidic linkages and stereochemistry
  • Congener-resolved composition, purity and analytical identification
  • Source provenance, processing history and chemical transformations
  • Physical condition, stability and evidence supporting handling or use

Out of scope

  • Taxonomy, cultivation and health of Panax plants
  • Complete composition and manufacture of ginseng extracts
  • Finished supplement, food or medicine formulation and labelling
  • Clinical treatment decisions and patient-specific dosing
  • Extraction equipment and production-process engineering

Why it exists Filled

Enable an agent to identify a ginsenoside, assess the composition and condition of material containing it, and determine which analytical, handling and use decisions the evidence supports.

Distinguishing features Filled

  • Require a defined glycosylated triterpenoid structure rather than identifying a material solely as a plant extract; representative ginsenoside Rg5 is classified as a triterpenoid saponin. [ChEBI](https://www.ebi.ac.uk/chebi/CHEBI%3A67992)
  • Distinguish a named congener from an unspecified total-ginsenoside fraction by requiring member-resolved identity and composition.
  • Compare sugar identity, attachment position, linkage and stereochemistry before treating two ginsenoside names as equivalent.
  • Distinguish a glycoside from its corresponding free aglycone by recording whether sugar residues remain attached.
  • Require a documented family-membership decision for related saponins rather than accepting botanical origin or a similar name as sufficient.

What robots and AI may and may not do Filled

Must not

  • Claim that ginsenosides cure or prevent disease without solid clinical evidence.
  • Advise people on blood thinners, diabetes medicines or in pregnancy to take ginseng products without medical advice.
  • Misstate ginsenoside content or species on product labels.
  • Promote harvesting of wild ginseng where it is protected.

Only with a human decision

  • Recommending ginseng products to patients alongside prescribed medicines.

May

  • Describe ginsenosides and the research on them from scientific sources, noting the strength of evidence.
  • Report ginsenoside content of products from authorized laboratory data.

Moral aspects Filled

  • Supplement marketing exploits limited research to sell products to sick people.
  • Wild ginseng is overharvested and protected in several countries.

Who is affected

  • Consumers and patients
  • Wild ginseng populations
  • Growers

Owners Filled

Steward

Nobody owns the compounds; producers answer for products that contain them.

Master systems

  • Chemical substance databases

Links to other meta-models Filled

parent

  • Q11173 - registry parent class

What else AI and robots need to interact with it Filled

Identity and identifiers required Filled

  • Vercy registry: vr.tr.ginsenoside
  • Wikidata: Q59662497 (https://www.wikidata.org/wiki/Q59662497)

Direct properties required Filled

  • Identity resolution: family only | named congener | structure confirmed | unresolved mixture
  • Congener identifiers: Structure-linked preferred name, synonyms, CAS number, PubChem CID, ChEBI identifier and EC number where established
  • Aglycone structure: Recorded skeleton and substitution pattern; proposed family membership separately qualified
  • Glycosylation pattern: Sugar identities, residue count, attachment positions, linkage sequence and anomeric configurations
  • Stereochemical assignment: Specified stereocentres and configurations | partially assigned | unresolved
  • Congener content: mg/g, mass %, or mol/L with analyte, matrix, method and reporting basis
  • Purity and impurity profile: Mass fraction or method-specific chromatographic area %, with water, solvents and related congeners separately identified
  • Physical form and dissolution behaviour: Solid form or solution composition; solubility in mg/mL at specified solvent, temperature and pH
  • Transformation history: Precursor, resulting congener, treatment conditions, sampling time and supporting analysis
  • Handling evidence status: Member- and material-specific safety documentation available | partial | absent

Recognition required Filled

  • Purified ginsenosides are white or off-white powders; identity requires laboratory analysis.

Capabilities and actions required Filled

  • Resolve a supplied name to a defined congener or retain an explicitly unresolved family-level identity.
  • Select reference standards and analytical methods appropriate to the proposed congeners and isomers.
  • Compare lots using congener profiles, assay basis and impurity evidence.
  • Track changes in ginsenoside composition during processing, storage or experimental conversion.
  • Determine whether material meets documented requirements for a specified analytical or experimental use.
  • Retrieve handling and regulatory evidence matched to the identified material and jurisdiction.

Hazards and failure modes required Filled

  • Interactions with blood thinners and diabetes medicines.
  • Adulterated or mislabelled ginseng products.

Standards and interfaces required Filled

  • Convention on International Trade in Endangered Species of Wild Fauna and Flora, CITES Secretariat, which lists American ginseng.

Context of use required Filled

  • Ginsenosides are encountered in plant material, extracts and analytical reference materials derived from or associated with Panax species.
  • They are studied in natural products chemistry and pharmacology and measured when characterizing the composition and consistency of botanical materials.

Sources Filled

  1. Wikidata item Q59662497: ginsenoside - identity and sense of the item
  2. Wikipedia: Ginsenoside - general description of the item

Open questions

  • Which authoritative family definition best matches the registry's intended scope, especially for non-dammarane compounds bearing ginsenoside names?
  • How should related notoginsenoside names, pseudoginsenoside names and deglycosylated metabolites be linked without creating duplicate identities?
  • Which analytical methods and reference standards adequately resolve the congeners and stereoisomers relevant to each intended material?
  • Which member-specific physical constants, storage limits and transformation pathways have reproducible experimental support?
  • Which safety classifications, exposure limits and use permissions are established for individual members, and where is evidence absent?

Machine files

Provenance

thing registry research (pass 2) · unreviewed

Built from: models/things/publications/thing-q59662497/spec.json